Adjuvant treatment for patients with stage I non-seminomatous germ cell tumors (NSGCT) could be active surveillance (AS), chemotherapy, or retro-peritoneal lymph node dissection (RLND). AS is the ...

Judge Ana Reyes was hearing arguments as part of a lawsuit filed by two LGBTQ+ advocacy groups on behalf of several ...

In 2024, the UVSS announced gender affirming care coverage — but long wait times and a lack of awareness of services creates barriers.